BioMed X is a new collaborative model between academia and industry developing innovative products in the fields of biomedicine, molecular biology, cell biology and diagnostics.
The BioMed X Institute located on the campus of the University of Heidelberg in Germany is a new collaborative model in which early-career biomedical scientists recruited globally work together on novel preclinical research projects. Interdisciplinary project teams conduct research in the fields of biomedicine, molecular biology, cell biology and diagnostics in an open-innovation lab facility under the guidance of experienced mentors from academia and industry while also expanding their scientific network and receiving training in entrepreneurship and leadership. Each team is typically sponsored by one of BioMedX’s corporate pharmaceutical partners, which include AbbVie, Boehringer Ingelheim, Janssen, Merck KGaA and Roche. Once a BioMedX project is completed, it is internalized into the development pipeline of the respective pharmaceutical partner.
In his two-part lecture, Dr. Christian Tidona, founder of BioMedX, explores this new model of collaboration between academia and industry.